Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phoscat
- Development stage
- Approved
- Lead developer
- Steadfast Medishield
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Phoscat is a brand of phosphate binders marketed by Steadfast Medishield (now Steadfast Limited) for the management of hyperphosphatemia in patients with Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD). The product line includes Phoscat, which primarily contains calcium acetate, and Phoscat FER, which contains ferric citrate. These agents function by binding to dietary phosphate within the gastrointestinal tract to form insoluble complexes that are subsequently excreted in the feces. This mechanism prevents the systemic absorption of phosphate, thereby helping to maintain normal serum phosphorus levels and reducing the risk of secondary hyperparathyroidism and metabolic bone disease in patients with end-stage renal disease.
- Brand names
- PhoscatPhoscat FER
- Other names
- calcium acetateferric citrate
Beyond the preview
Go deeper on Phoscat.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phoscat.